Authors
Chernenko S.V.1, Surov D.A.2, Korzhuk M.S.1, 2, Agasiev M.V.3, Eselevich R.V.2, Rezina A.I.4
1 Omsk state medical university, Omsk
2 S.M. Kirov Military medical academy, St. Petersburg
3 Moscow city oncological hospital №62, Moscow
4 North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg
Abstract
The article describes a series of clinical cases of air leak syndrome in patients suffering from COVID-19 coronavirus infection. The number of observations was 54. The number of men was slightly more than women — 30 versus 24. Qualitative and quantitative characteristics of patients were indicated, including gender, age, degree of radiological changes and the area of lesion of the lung parenchyma by CT. Most patients had III-IV degrees of severity of the lesion. The presence and profile of concomitant pathology are reflected. When analyzing the timing of the air leak syndrome onset, it was revealed that the majority of episodes of air leak syndrome developed at 2-4 weeks from the onset of the disease. The issues of therapeutic measures for air leak syndrome with the participation of thoracic surgeons are considered. The results of treatment are presented. In 2/3 of patients, the air leak syndrome was cured and stopped without the use of invasive procedures. 1/3 of the patients needed chest tube drainage, or/and mediastinal drainage. 6 patients died, 3 men and 3 women. The cause of death was progressive SARS CoV 2-pneumonia with the development of respiratory, and then — multiple organ failure. There were no fatal outcomes attributed to the air leak syndrome. There were no difficulties with ensuring adequate drainage of air retention. Favorable results were achieved by the earliest possible involvement of thoracic surgeons in the treatment of patients with air leak syndrome.
Keywords: COVID-19, air leak syndrome, pneumothorax, pneumomediastinum, severity score, chest tube drainage, mediastinal drainage, conservative treatment, thoracic surgeon.
References
1. Sabharwal P, Chakraborty S, Tyagi N, Kumar R, Taneja A. Spontaneous Air-leak Syndrome and COVID-19: A Multifaceted Challenge. Indian J Crit Care Med. 2021; 25(5): 584-587. doi:10.5005/jp-journals-10071-23819.
2. Rashedi S, Mardani M, Fooladgar M, Aliannejad R. Spontaneous pneumomediastinum, pneumopericardium, pneumothorax, and subcutaneous emphysema in a patient with COVID 19. Radiol Case Rep. 2021; 16(5): 1158-1161. doi:10.1016/j.radcr.2021.02.069.
3. Patrícia Dionísio, Luís Martins, Susana Moreira, Alda Manique, Rita Macedo, Fátima Caeiro, Luísa Boal, and Cristina Bárbara Spontaneous pneumomediastinum: experience in 18 patients during the last 12 years. J Bras Pneumol. 2017; 43(2): 101-105.
4. Abakumov MM, Shamba KhL, Danielian ShN. Spontaneous emphysema of the mediastinum. Khirurgiya. 2010; 10: 17-21. (In Russ).
5. Abakumov MM, Shamba KhL, Danielian ShN. Spontaneous mediastinal emphysema. Khirurgiya. 2010; 2: 47-50. (In Russ).
6. Fishman AP, Elias JA, Fishman JA, Grippi MA, M R, Senior, Pack AI. Fishman’s Pulmonary Disease and Disorders. Philadelphia: McGraw-Hill Medical; 2008.
7. Wang XH, Duan J, Han X, et al. High incidence and mortality of pneumothorax in critically Ill patients with COVID-19. Heart Lung. 2021; 50(1): 37-43. doi:10.1016/j.hrtlng.2020.10.002.
8. Song IH, Lee SY, Lee SJ, Choy WS. Diagnosis and treatment of spontaneous pneumomediastinum experience at a single institution for 10 years. Gen Thorac Cardiovasc Surg. 2017; 65(5): 280-284.
9. Dajer-Fadel WL, Argüero-Sánchez R, Ibarra-Pérez C, Navarro-Reynoso FP. Systematic review of spontaneous pneumomediastinum a survey of 22 years’ data. Asian Cardiovasc Thorac Ann. 2014; 22(8): 997-1002.
10. Wang W, Gao R, Zheng Y, Jiang L. COVID-19 with spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema. J Travel Med. 2020; Aug 20: 27-32. doi: 10.1093/jtm/taaa062. PMID: 32330274; PMCID: PMC7188125. 5.
11. Xiang C, Wu G. SARS-CoV-2 pneumonia with subcutaneous emphysema, mediastinal emphysema, and pneumothorax: A case report. Medicine (Baltimore). 2020; 99(20): 20208. doi: 10.1097/MD.0000000000020208.
12. Sethi SM, Ahmed AS, Hanif S, Aqeel M, Zubairi ABS. Subcutaneous emphysema and pneumomediastinum in patients with COVID-19 disease; case series from a tertiary care hospital in Pakistan. Epidemiol Infect. 2021; 149: e37. Published online 2021 Jan 20.
